Enanta Pharmaceuticals Inc. sell JPMorgan Chase & Co.
Start price
09.08.23
/
50%
€14.70
Target price
09.08.24
€12.75
Performance (%)
-9.52%
Price
06.05.24
€13.30
Summary
This prediction is currently active. With a performance of -9.52%, the SELL prediction by JPMorgan_Chase___Co_ is trending in the right direction. This prediction currently runs until 09.08.24. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Enanta Pharmaceuticals Inc. | 9.917% | 9.917% |
iShares Core DAX® | 0.476% | -0.039% |
iShares Nasdaq 100 | 1.290% | 0.504% |
iShares Nikkei 225® | 1.300% | -2.135% |
iShares S&P 500 | 0.829% | 0.193% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Enanta Pharmaceuticals Inc. diskutieren
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating. They now have a $14.00 price target on the stock.
Ratings data for ENTA provided by MarketBeat